Zacks Research Raises Earnings Estimates for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC) – Investment analysts at Zacks Research lifted their FY2024 earnings per share estimates for shares of Teladoc Health in a report issued on Wednesday, November 13th. Zacks Research analyst R. Department now forecasts that the health services provider will post earnings of ($1.15) per share for the year, up from their prior estimate of ($1.31). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.17) per share. Zacks Research also issued estimates for Teladoc Health’s Q4 2024 earnings at ($0.19) EPS, Q1 2025 earnings at ($0.38) EPS, Q2 2025 earnings at ($0.28) EPS, Q3 2025 earnings at ($0.27) EPS, Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($1.05) EPS, Q1 2026 earnings at ($0.37) EPS, Q2 2026 earnings at ($0.22) EPS, Q3 2026 earnings at ($0.21) EPS and FY2026 earnings at ($0.89) EPS.

Several other equities research analysts have also commented on the company. Stifel Nicolaus decreased their price target on Teladoc Health from $16.00 to $9.00 and set a “hold” rating on the stock in a research note on Thursday, August 1st. Canaccord Genuity Group decreased their price target on Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. The Goldman Sachs Group started coverage on Teladoc Health in a research note on Friday. They set a “buy” rating and a $14.00 price target on the stock. TD Cowen reduced their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday, October 31st. Finally, JPMorgan Chase & Co. reduced their target price on Teladoc Health from $16.00 to $9.00 and set a “neutral” rating on the stock in a research note on Monday, August 26th. Fourteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $12.08.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $9.06 on Monday. The business’s 50 day simple moving average is $8.93 and its 200-day simple moving average is $9.34. The firm has a market capitalization of $1.56 billion, a price-to-earnings ratio of -1.57 and a beta of 0.90. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $22.54.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.10. The business had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%.

Insider Buying and Selling at Teladoc Health

In other news, CFO Mala Murthy sold 8,750 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the completion of the sale, the chief financial officer now directly owns 85,767 shares in the company, valued at $614,091.72. This represents a 9.26 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Michael Willem Waters sold 4,218 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $30,200.88. Following the sale, the chief operating officer now owns 78,309 shares of the company’s stock, valued at approximately $560,692.44. The trade was a 5.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 20,051 shares of company stock worth $143,565. Insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Large investors have recently added to or reduced their stakes in the stock. Signaturefd LLC increased its holdings in Teladoc Health by 148.7% in the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,715 shares in the last quarter. International Assets Investment Management LLC purchased a new position in Teladoc Health in the 2nd quarter valued at about $29,000. Blue Trust Inc. boosted its position in Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after buying an additional 1,854 shares during the last quarter. Doheny Asset Management CA purchased a new position in Teladoc Health in the 2nd quarter valued at about $46,000. Finally, Benjamin F. Edwards & Company Inc. boosted its position in Teladoc Health by 209.8% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock valued at $49,000 after buying an additional 3,396 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.